News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
73–108
Matches
3026
Sources here
27
Companies here
28
Search results Stored financial headlines

Active search

3026 matching headlines

Ticker or company: ALIMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Twin Lions Management (MBUU) discloses 2.6% Malibu Boats position in 13G/A

Twin Lions Management LLC and Timothy Abbott have reported a beneficial ownership of 504,210 shares, or 2.6%, of Malibu Boats, Inc. Class A Common Stock as of June 30, 2026, through a Schedule 13G/A filing. The shares are directly owned by advisory clients of …

MBUU main company
Sharemaestro market context Price above Trend Line 52 weeks -25.2% · Next-week setup negative 44.6% MBUU stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ARK reports 9.59% stake in Pacific Biosciences (PACB)

ARK Investment Management LLC and Catherine D. Wood have reported a beneficial ownership of 9.59% in Pacific Biosciences of California, Inc. (PACB), amounting to 29,781,416 shares. This disclosure, made via a SCHEDULE 13G/A filing, details their sole and shared voting and dispositive powers over …

PACB main company
Sharemaestro market context Price below Trend Line 52 weeks -16.7% · Next-week setup negative 41.8% PACB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Catalyst Watch: Eyes on Walmart, Alibaba, Reddit, and McDonald's energy drink push

[Stock exchange building columns stock market finance] alexsl Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. MONDAY - AUGUST 17 * …

BABA main company BABA80 main company BABA01 main company BABAN main company 9988 main company BABA34 main company +6 more
Sharemaestro market context Price below Trend Line 52 weeks +18.9% · Next-week setup positive 56.3% BABA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Alibaba Group Holding Limited (NYSE

Robbins Geller Rudman & Dowd LLP announced a class action lawsuit against Alibaba Group Holding Limited (NYSE: BABA) on behalf of investors who purchased securities between June 26, 2025, and June 24, 2026. The lawsuit alleges that Alibaba made false and misleading statements by …

BABA main company
Sharemaestro market context Price below Trend Line 52 weeks +1.6% BABA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Aligos Therapeutics Company Profile & Introduction

This document is intended to provide a company profile and introduction for Aligos Therapeutics. Further details about the company's operations, financial performance, and strategic direction would typically be included in a complete profile.

ALGS main company
Sharemaestro market context Price above Trend Line 52 weeks -32.5% ALGS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nomura entities report zero Malibu Boats (MBUU) ownership in amended 13G

Nomura Asset Management International Inc. and Nomura Investment Management Business Trust have filed an amended Schedule 13G/A, reporting zero beneficial ownership of Malibu Boats (MBUU) Class A Common Stock. This filing indicates that the Nomura entities now hold 0 shares, representing 0% of the …

MBUU main company
Sharemaestro market context Price above Trend Line 52 weeks -25.2% · Next-week setup negative 44.6% MBUU stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Alibaba Group Holding Ltd. ADR outperforms market on strong trading day

Alibaba Group Holding Ltd. ADR (BABA) rallied 1.35% to $123.81 on Friday, despite an overall poor trading session for the stock market where the NASDAQ Composite Index and Dow Jones Industrial Average both fell. This performance ended a three-day losing streak for the ADR.

BABA main company
Sharemaestro market context Price below Trend Line 52 weeks +1.6% BABA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Align Technology Inc. stock outperforms competitors on strong trading day

Align Technology Inc. (ALGN) saw its stock rise by 2.90% to $181.31, outperforming a generally down market where both the S&P 500 Index and Dow Jones Industrial Average experienced slight declines. This marked the third consecutive day of gains for the company's stock.

ALGN main company ALGN main company
Sharemaestro market context Price above Trend Line 52 weeks +21.2% ALGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Denali Therapeutics CEO Ryan J. Watts Donates 32,220 Shares to Donor Advised Fund

Denali Therapeutics Inc. CEO, Ryan J. Watts, donated 32,220 shares of common stock to a donor-advised fund on August 12, 2026, as disclosed in an SEC Form 4 filing. This charitable gift, valued at $0, was reported on August 14, 2026. Following the donation, …

DNLI main company
Sharemaestro market context Trend signal active 52 weeks +57.5% DNLI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Freedom Broker experts: quarterly results strengthened Alico’s liquidity

Freedom Broker analysts have upgraded Alico Inc. (ALCO) to "Buy" from "Hold" and raised their target price due to strengthening liquidity and a strategic shift towards monetizing its land portfolio. Alico's Q3 fiscal 2026 results showed revenue beat forecasts thanks to a one-off variable …

ALCO main company
Sharemaestro market context Price below Trend Line 52 weeks +15.4% ALCO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Latham Represents Zentalis Pharmaceuticals in US$80.5 Million Underwritten Public Offering

Latham & Watkins LLP advised Zentalis Pharmaceuticals, Inc. in its recent underwritten public offering, which is expected to generate approximately US$80.5 million in gross proceeds. The offering involved 23,000,000 shares of common stock at US$3.50 per share, with an option for underwriters to purchase …

ZNTL main company
Sharemaestro market context Trend signal active 52 weeks +78.9% · Next-week setup negative 44.0% ZNTL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

A Dozen Universities Allotted Dentistry Research Grants From Align Technology

Align Technology Inc. has awarded 12 research grants to universities globally as part of its Fifteenth Annual Research Award Program. These grants support various dentistry topics, emphasizing Align's commitment to advancing scientific inquiry and innovation in orthodontics and dental care. The funded studies aim …

ALGN main company
Sharemaestro market context Price above Trend Line 52 weeks +21.2% ALGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Ameriprise Financial (PSNL) discloses 5.8% ownership stake in Personalis common stock

Ameriprise Financial, Inc. has filed an amended passive investment disclosure (SCHEDULE 13G/A) revealing a 5.8% ownership stake in Personalis, Inc. common stock as of June 30, 2026. This ownership includes shared voting power over 6,054,599 shares and shared dispositive power over 6,086,315 shares. Ameriprise …

PSNL main company
Sharemaestro market context Trend signal active 52 weeks +190.7% PSNL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Alibaba Group (BABA) reports $509M in 13F U.S. equity holdings

Alibaba Group Holding Ltd has filed its quarterly Form 13F as an institutional investment manager, disclosing two reportable U.S. equity positions with an aggregate value of over $509 million. The filing, signed by Company Secretary Jinwei Zhang, indicates that Alibaba Group filed this report …

BABA main company
Sharemaestro market context Price below Trend Line 52 weeks +1.6% BABA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Deep Track Capital (PSNL) reports 4,000,000 Personalis shares, now under 5% ownership

Deep Track Capital, LP, Deep Track Biotechnology Master Fund, Ltd., and David Kroin have filed an amended Schedule 13G/A for Personalis, Inc. (PSNL). The filing indicates that as of June 30, 2026, the group beneficially owned 4,000,000 shares of Personalis common stock, representing 3.82% …

PSNL main company
Sharemaestro market context Trend signal active 52 weeks +190.7% PSNL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Deutsche Bank Adjusts Ryman Hospitality Properties PT to $152 From $150, Maintains Buy Rating

Deutsche Bank has increased its price target for Ryman Hospitality Properties (RHP) to $152 from $150, while reiterating a Buy rating on the stock. This adjustment reflects an updated outlook from the financial institution on the real estate investment trust specializing in upscale convention …

RHP main company
Sharemaestro market context Trend signal active 52 weeks +31.9% · Next-week setup positive 55.2% RHP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Rci hospitality director Yura Barabash buys $24,233 in company stock

Yura V. Barabash, a director at RCI Hospitality Holdings, Inc. (NASDAQ:RICK), recently purchased 888 shares of company stock for $24,233, increasing his direct ownership to 2,037 shares. This insider activity follows a positive fiscal third-quarter report for RCI Hospitality, which saw a 4% revenue …

RICK main company
Sharemaestro market context New activity signal 52 weeks -17.5% · Next-week setup negative 34.7% RICK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CREATIVE REALITIES, INC. 2026: Revenue $21.51M, EPS ($0.41) — 10-Q Summary

Creative Realities, Inc. (CREX) reported significant growth for the quarter, with revenue increasing to $21.51M from $13.03M year-over-year, primarily due to the acquisition of CDM. Despite the revenue increase, the company recorded a net loss of ($4.3M) and a diluted loss per share of …

CREX main company
Sharemaestro market context Price below Trend Line 52 weeks +26.6% CREX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Zentalis adds USD 80.5m as azenosertib nears pivotal test

Zentalis Pharmaceuticals has raised approximately USD 80.5 million through an equity offering to fund the late-stage development and pre-commercial activities for its oral WEE1 inhibitor, azenosertib. The drug is being evaluated for Cyclin E1-positive platinum-resistant ovarian cancer, with Phase II data expected by year-end …

ZNTL main company
Sharemaestro market context Trend signal active 52 weeks +78.9% · Next-week setup negative 44.0% ZNTL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Calian Group Q3 Earnings Call Highlights

Key Points Interested in Calian Group Ltd.? Here are five stocks we like better. Record Q3 performance: Revenue rose 20% year over year to CAD 230 million, while adjusted EBITDA increased 35% to CAD 26 million. Organic growth reached 16%, and the adjusted EBITDA …

CGY main company
Sharemaestro market context Trend signal active 52 weeks +72.9% CGY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context